AMSBIO announce a new range of ready-to-use adeno-associated virus (AAV) biosensor products. These viruses encode your chosen biosensor, either calcium or glutamate sensor and are ready for in vivo injection. The new range of Calcium or Glutamate biosensor products comes with a choice of promoter and the ability to include the Cre inducible (FLEx-ON) expression. […]
Uppsala, Sweden: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, announced today the appointment of Gerrit van den Dool to its Board of Directors, as a Non-Executive Director. With more than 25 years’ experience in the life science industry and with his expertise in sales […]
MENLO PARK, Calif. — Synthomics, Inc., an emerging developer of next-generation systems for oligonucleotide synthesis, announced today that it has completed seed round financing and has launched an early access program for its end-to-end DNA synthesis platform. The financing round was anchored by TEEC Angel Fund (https://www.teec-angel.com), a Palo Alto, CA-based Micro VC fund with an […]
Unique technology portfolio enables design space characterization, effective translation to the large-scale and enhanced process analytics Goettingen, Germany / Aubagne, France —Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, has developed an innovative and fully integrated technology platform to meet the requirements of today’s upstream bioprocessing. It will allow customers to adopt […]
New Two-Year Agreement with Belgian University to Focus on Detecting Genetic Abnormalities in Cell-free DNA and Embryo Biopsies SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today announced that it is extending its collaboration with the Centre for Human Genetics of the University of Leuven and the University Hospital of Leuven in Belgium. Joris Vermeesch, […]
Mountain View, CA—Takara Bio USA Holdings, Inc. (“TBUSH”) announced that it has completed the acquisition of Rubicon Genomics, Inc. (“Rubicon”), Rubicon has become a wholly-owned subsidiary of TBUSH as of January 17, 2017 (US local time). The Takara Bio Group provides a wide range of life science products and services under the Takara, Clontech, and […]
SAN ANTONIO–StemBioSys Inc. announced today that it has entered into an agreement with VWR (NASDAQ: VWR) to distribute and market StemBioSys products. VWR, the leading global independent provider of product and service solutions to laboratory and production facilities, will be the exclusive distributor for StemBioSys in both the United States and Canada. “I cannot overstate […]
Renewal continues fundamental research into advanced biofuels Large team of researchers focused on Synthetic Genomics’ core synthetic biology technologies Progress continues toward development of algae-based transportation fuels LA JOLLA, Calif.—-Synthetic Genomics, Inc. and ExxonMobil (NYSE: XOM) announced today that they have extended their agreement to conduct joint research into advanced algae biofuels after making significant […]
908 Devices, a pioneer of purpose-built analytical devices for chemical and biomolecule analysis, today announced significant product enhancements for ZipChip™, an innovative system that provides high-quality separation capabilities as a front-end for mass spectrometry (MS). An integrated autosampler, built-in chip recognition intelligence and application specific assay kits are being released to radically improve process efficiencies for […]
Provides Fast, Easy Way for Seven Bridges Users to Access and Analyze Data Generated in Europe, under the Protection of EU Data Protection Regulations CAMBRIDGE, Mass. – Seven Bridges, the biomedical data analysis company, today announced that the Seven Bridges Platform is now live on the Amazon Web Services (AWS) EU (Frankfurt) Region in Frankfurt, Germany, […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
